Presented by:

Rocco Marotta, MD, PhD

Director of the Center for the Treatment and Study of Neuropsychiatric Disorders

Please note: This event is hosted by The Dorm, and Continuing Education credits are granted through them, not Silver Hill Hospital. 

Learning Objectives

• Distinguish early symptoms of Treatment resistant schizophrenia.
• Identify evidence-based treatment options specific to the young adult population.
• Describe common barriers to diagnosis and care.

Target Audience

This educational activity is intended for behavioral health professionals, including Psychologists, Social Workers, Counselors, and MFT’s.

REGISTER HERE

Treatment resistant schizophrenia refers to the proportion of schizophrenia patients who continue to have symptoms and poor outcomes despite treatment. We will take a careful look at how this is defined, such as failure of different antipsychotics, neuroimaging, and neurobiological characteristics of treatment resistant schizophrenia. We further review the current treatment strategies available, including medication combinations, and psychotherapies. We conclude by highlighting common barriers to early diagnosis and treatment in young adults.